SAB Biotherapeutics (SABS) Interest Coverage Ratio Growth (3y) (2024 - 2026)
Powered by 
Analysis
SAB Biotherapeutics (SABS) Interest Coverage Ratio Growth (3y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -44.22% |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 33.30% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -35.50% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 81.16% |
| 10 | SAB Biotherapeutics | 296.68 Mn | 296.68 Mn | - | -63.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -63.68% |
| Mar 31, 2026 | -58.45% |
| Dec 31, 2025 | -40.49% |
| Sep 30, 2025 | -38.37% |
| Jun 30, 2025 | -18.30% |
| Mar 31, 2025 | -18.47% |
| Dec 31, 2024 | -8.42% |
| Sep 30, 2024 | -41.83% |
| Jun 30, 2024 | -41.59% |
| Mar 31, 2024 | -150.82% |